Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
about
Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophilsExpression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiationIntestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activityCloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophilsMouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptorEosinophils in the 1990s: new perspectives on their role in health and diseaseEotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytesMolecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophilsPlatelets in patients with aspirin-exacerbated respiratory diseaseHuman ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytesInhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in manPharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosanMolecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophilsRole of platelets in neuroinflammation: a wide-angle perspectiveThe role of platelet activating factor in allergic respiratory diseaseTransepithelial migration of activated eosinophils induces a decrease of E-cadherin expression in cultured human nasal epithelial cells.Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction.Retrospective study on fluticasone propionate aqueous nasal spray efficacy in patients with allergic rhinitis: evaluation of clinical and laboratory parameters.Sequencing and cloning of the cDNA of guinea pig eosinophil major basic protein.Bimodal effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesisEffect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjectsSignaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells.The role of chemokines in cutaneous allergic inflammation.Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.The role of chemokines in Hodgkin's disease.Immune mechanisms in Onchocerca volvulus-mediated corneal disease (river blindness).Platelet-activating factor causes ventilation-perfusion mismatch in humans.Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways.HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes.Human eosinophils express functional interleukin 2 receptors.Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor.Mucosal dysfunction and damage induced by platelet activating factor (PAF).Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.Recombinant interferon-gamma primes alveolar macrophages cultured in vitro for the release of leukotriene B4 in response to IgG stimulationInvestigation of the endogenous chemoattractants involved in 111In-eosinophil accumulation in passive cutaneous anaphylactic reactions in the guinea-pig.Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.Mast cells and neuroinflammation.
P2860
Q24293111-C347D856-3ABF-494F-ABA5-62B93D5174E3Q24528229-5E03A694-F6FF-4847-BEBD-B0200A6C6DA7Q24541516-D002A69C-9B56-434C-BBDB-0DB40EB9F8F7Q24562774-65CCF9E4-4DFD-4604-9056-7308A0348267Q24629279-CD5FD847-453A-4523-8FC1-41889F4631CFQ24648898-87062FB1-0355-4752-AFA9-5BBE61E4E05CQ24669740-07B77A4D-7423-47CA-9098-3744A9E7E215Q24678192-4ED8642E-6BDF-4174-A664-B06C4361B689Q28080840-0EEC6E47-001A-4B9E-8007-D92EF277C8F6Q28274800-53F63570-9A64-4927-8426-D802815EB51BQ28326803-BC393F83-A5B2-4AD4-A006-BC58D84DC1BAQ28360120-FF81AD40-54BE-4655-ABAC-82649B34ACC5Q28368966-E940A850-690F-4A12-8FC9-F4F3D7AE7F3CQ28393808-C4FD4081-3345-4B01-A431-506046C68D3FQ28768533-443E2487-AE79-4CD2-8468-D34D808BEF08Q30650700-B97946CB-E2C2-4EAD-B629-1A7C3F830EF4Q30847683-63C3BB94-1943-4717-BE2E-278F123A187CQ31891109-54A5A1A3-35E8-4C7F-A926-FD7AF40F96F4Q33261227-6DFC6A78-0D0E-4D93-A739-081F874EC3F0Q33490624-3CABFDD2-519F-40AD-965B-6661F33D465EQ33560636-6F1E50FA-E6D7-4827-9D0F-9598CAC259AFQ33567912-5B63DF81-1110-4755-BA64-AAF0136B3388Q33604066-07BD0E11-331D-4343-87D2-ED0DD5F6EF2EQ33655634-84A1AD09-AEC0-4BCA-ACB8-84DC4001E2B0Q33737280-C8758520-A156-47B9-A123-E7B9489C6A7CQ33840598-03B65135-C018-40B5-B8B8-4EE736E1D724Q33929840-B4FD0ED5-3540-439E-A701-CCEAA202DD42Q34109376-E333FE51-67A0-42FF-A5A6-08BB5BC3565BQ34119627-F443C7A8-55DF-4F6F-AA23-0253B8814234Q34137821-266CCDD5-DA32-4FB4-9AA9-26B9ED63AC3DQ34178917-60D1833C-98A7-4EC8-B4BE-B48953962CC6Q34197541-15A83310-C6F8-42F4-85F2-B5C8362DBF14Q34264529-DE749683-715E-434C-842B-521E1A0DE760Q34272784-0E4860C8-1C74-46B7-8F57-47D0A84F4473Q34359937-904DDF4D-1130-4C1E-9F87-A0B9297D8297Q34417767-DAF367E9-656A-4F94-B271-D9F0C654265EQ34573260-F4D452B7-4052-43FC-8A7A-24A4E40E21A7Q34792358-CF2C82D7-AF4F-4469-98D4-3C8C33652A49Q34792443-17F0DF1C-C3F2-4A4C-AE18-505B3AD4A50AQ34810678-ED944F98-FC4E-4116-A98C-E27E3BCF5DD8
P2860
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Platelet-activating factor. A ...... factor for human eosinophils.
@en
type
label
Platelet-activating factor. A ...... factor for human eosinophils.
@en
prefLabel
Platelet-activating factor. A ...... factor for human eosinophils.
@en
P2093
P2860
P356
P1476
Platelet-activating factor. A ...... c factor for human eosinophils
@en
P2093
P2860
P304
P356
10.1172/JCI112765
P407
P577
1986-12-01T00:00:00Z